Israel Cancer Research Fund - Chicago Chapter

Call Directions Website Contact the business

Israel Cancer Research Fund - Chicago Chapter ICRF provides pivotal grants to outstanding Israeli scientists to support groundbreaking cancer research across Israel.

Israel Cancer Research Fund (ICRF) is a nationwide charitable organization that receives its total income from private donations. ICRF was founded in 1975 by a group of American and Canadian researchers, oncologists, and lay people determined to harness Israel's educational and scientific resources in the fight against cancer. Its initial purpose was to stem the "brain drain" of Israeli researchers by providing funds for postdoctoral fellowships for young Ph.D.'s. ICRF is the only U.S.-based charity solely devoted to supporting cancer research in Israel. Since its inception, ICRF has provided more than $72 million in funding to support innovative studies by Israeli scientists. Our awardees are selected through a rigorous peer-review process that is conducted by a world-class scientific panel. We support individuals at all of the major research institutions in Israel. ICRF-funded researchers have been making significant progress and have been able to develop improved chemotherapies, advanced techniques in bone marrow transplantation, and an enhanced understanding of tumor suppressor genes. By continuing to support cancer research in Israel for the benefit of all mankind, the ICRF:

makes it possible for scientists to utilize Israel's unique population of diverse ethnic groups which afford unequalled opportunities to study genetic and environmental data that contribute to cancer;

places a strong emphasis on young scientists pioneering in new directions with fresh approaches to areas of research that have challenged the experts;

respects and draws upon Israel's unparalleled convergence of some of the finest scientists and physicians in the free world - a resource that must not be lured to conduct research outside Israel.

For children and families facing neuroblastoma, new research can bring new possibilities and new hope.ICRF and Shir for ...
10/14/2026

For children and families facing neuroblastoma, new research can bring new possibilities and new hope.

ICRF and Shir for Life are partnering to fund new research into neuroblastoma, a rare and often difficult-to-treat childhood cancer.

The three-year, $180,000 grant will support Prof. Ravid Straussman of the Weizmann Institute of Science as he investigates how bacteria within neuroblastoma tumors may influence tumor development, immune activity, and response to treatment.

Through this partnership, ICRF and Shir for Life are supporting research that could lead to new treatment options and greater hope for children and families facing neuroblastoma.

Read the full announcement here: https://www.icrfonline.org/news/israel-cancer-research-fund-and-shir-for-life-partner-to-fund-research-on-the-tumor-microbiome-in-neuroblastoma/

Final chance to join us! Tower of Hope Gala Registration deadline is Wednesday, October 14. Don't miss out! ICRF CHICAGO...
10/08/2026

Final chance to join us! Tower of Hope Gala Registration deadline is Wednesday, October 14. Don't miss out!

ICRF CHICAGO TOWER OF HOPE GALA
Wednesday, October 28, 2026, 6:00 pm | The Westin Chicago North Shore

The event will feature acclaimed storyteller, best-selling author, and two-time cancer survivor Tania Katan.

We’ll also present the inaugural David Abramson Memorial Award, honoring David’s lasting legacy and commitment to ICRF’s mission.

Get tickets, tributes, and sponsorships here: https://my.onecause.com/event/organizations/08ce6e02-a029-47e9-8826-108717dea6a9/events/vevt:dd3e7267-3473-450e-8e63-46de7405c142/home/story

Today is  , and your donor-advised fund can help end cancer.At ICRF, your DAF gift gives Israel's leading scientists the...
10/08/2026

Today is , and your donor-advised fund can help end cancer.

At ICRF, your DAF gift gives Israel's leading scientists the resources to chase bold ideas, develop new approaches to treatment, and make discoveries that reach patients and families around the world.

Whether you already have a DAF or are considering one, today is your chance to put your charitable dollars to work for Israel's cancer research.

👉 Give through your DAF today: https://www.icrfonline.org/donor-advised-funds/

📸 credit: Kenes Tours

Today, we remember October 7, a day that changed Israel and the world forever. We remember those we lost, those who were...
10/07/2026

Today, we remember October 7, a day that changed Israel and the world forever.

We remember those we lost, those who were injured, and the families who continue to carry unimaginable pain. Our hearts are with the communities forever changed and the strength of the people of Israel who continue to move forward in the face of profound loss.

May we continue to stand together in hope and look toward a future filled with peace and healing.

Only 5–10% of breast cancers are hereditary.That means most women diagnosed have little to no family history of the dise...
10/06/2026

Only 5–10% of breast cancers are hereditary.

That means most women diagnosed have little to no family history of the disease, which is exactly why Dr. Julie Lang says screening matters for every woman over 40.

Dr. Lang is a breast cancer surgeon, researcher, and member of ICRF's Scientific Review Panel. In her lab and clinic, she's helping uncover how blood tests can detect signs of recurrence before they appear on scans, and how the environment around aggressive tumors helps them evade the immune system.

As she puts it, "My goal is to combine scientific curiosity with compassion. I want to offer patients the best treatment available today while also working to develop better treatments for tomorrow."

Read the full interview to learn more about her work and excitement for the bold research coming out of Israel: https://www.icrfonline.org/news/science-made-simple-dr-julie-lang-on-the-future-of-breast-cancer-research-and-care/

October is Breast Cancer Awareness Month, a time to recognize how far we’ve come in the fight against breast cancer and ...
10/01/2026

October is Breast Cancer Awareness Month, a time to recognize how far we’ve come in the fight against breast cancer and the research that continues to shape its future.💗 Our latest newsletter explores the research driving progress in breast cancer and beyond, from precision medicine and AI to earlier cancer detection.

Inside this month's issue:
🔬 Meet breast cancer researcher Dr. Julie Lang
🧬 Discover how ICRF-funded scientists are advancing treatment for multiple myeloma
🤖 See how Israeli researchers are using AI to transform cancer diagnosis and treatment
🎥 Hear how an early ICRF grant helped launch the career of Prof. Eli Pikarsky
And more!

Read the latest from ICRF and discover how research today is shaping the future of cancer care: https://conta.cc/4hjaOr1

For patients and families facing a rare cancer, research can mean more than a discovery. It can mean the possibility of ...
09/30/2026

For patients and families facing a rare cancer, research can mean more than a discovery. It can mean the possibility of having more options.

Prof. Ora Schueler-Furman of the Hebrew University of Jerusalem is taking on one of the challenges of Ewing sarcoma, a rare and aggressive cancer that primarily affects children and young adults.

With support from an ICRF grant, her team is using AI-based design tools and laboratory research to explore a hidden site on the protein that drives Ewing sarcoma. Their goal is to develop new ways to identify and ultimately target these cancer cells.

Research like this expands what we know about rare cancers and helps lay the groundwork for future advances.

🔬 Learn more about Prof. Schueler-Furman’s research: https://www.icrfonline.org/grants/ora-schueler-furman-phd/

Make sure you register for the ICRF Chicago Tower of Hope Gala on Wednesday, October 28. It will be an inspiring evening...
09/25/2026

Make sure you register for the ICRF Chicago Tower of Hope Gala on Wednesday, October 28. It will be an inspiring evening celebrating science, Israeli innovation, and hope.

The event will feature acclaimed storyteller, best-selling author, and two-time cancer survivor Tania Katan.

We’ll also present the inaugural David Abramson Memorial Award, honoring David’s lasting legacy and commitment to ICRF’s mission.

Join us in supporting cancer research discoveries that start in Israel and save lives worldwide. Get tickets, tributes, and sponsorships now: https://my.onecause.com/event/organizations/08ce6e02-a029-47e9-8826-108717dea6a9/events/vevt:dd3e7267-3473-450e-8e63-46de7405c142/home/story

Ovarian cancer can be difficult to detect, making awareness and access to information especially important. This  , we’r...
09/25/2026

Ovarian cancer can be difficult to detect, making awareness and access to information especially important. This , we’re sharing the facts and highlighting resources that can help women and families make informed decisions about their health.

ICRF is proud to be a National Partner of the Sharsheret Summit 2026, a free virtual series bringing the latest information on breast and ovarian cancer. From AI screening and menopause to nutrition and community resources, the Summit features expert-led sessions designed to inform, empower and support.

Join Sharsheret now through October 23 and learn more about breast and ovarian cancer.

👉 Learn more and register: sharsheret.org/sharsheret-summit/

Artificial intelligence is opening new possibilities in cancer research, and ICRF-funded researchers are helping lead th...
09/24/2026

Artificial intelligence is opening new possibilities in cancer research, and ICRF-funded researchers are helping lead the way!

A new feature from the Jewish Telegraphic Agency highlights the work of Dr. Debbie Anaby, Prof. Ron Kimmel, and Dr. Talia Golan. Their research is exploring how AI and advanced technologies can transform the way cancer is detected, understood, and treated.

Read the full article to learn more about their research and the growing role of AI in cancer science.

🔗 https://www.jta.org/2026/09/24/israel/how-israeli-researchers-are-using-ai-to-transform-cancer-treatment-and-diagnoses

Address

One Northfield Plaza, #235
Northfield, IL
60093

Opening Hours

Monday 8am - 4pm
Tuesday 8am - 4pm
Wednesday 8am - 4pm
Thursday 8am - 4pm
Friday 8am - 4pm

Telephone

+18474411824

Alerts

Be the first to know and let us send you an email when Israel Cancer Research Fund - Chicago Chapter posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Israel Cancer Research Fund - Chicago Chapter:

Share